Literature DB >> 24996649

Continuation of venous thromboembolism prophylaxis after hospital discharge into the outpatient setting: the ACCEPT study.

Sebastian M Schellong1, Jürgen Kaiser, Peter Bramlage.   

Abstract

Transition from the hospital into the outpatient setting is a critical event for the appropriate provision of VTE prophylaxis. Data for this transition for the situation in Germany is scant. This was a retrospective, observational study in patients receiving in-hospital thromboprophylaxis and discharged with or without a recommendation to continue. Patient with previous thromboembolism were excluded. A total of 3,211 patients were identified by 518 physicians of which 2,853 had all data available for the present analysis; mean patient's age was 57.4 ± 17.5 (SD) years, 48.2% were male and bodyweight was 79.8 ± 16.1 kg. During hospitalization 95.5% of surgical and 84.0% of medical patients received any thromboprophylaxis, the mean hospital duration being 12.7 ± 20.3 days. Surgical patients had high, medium and low risk in 53.8, 37.1 and 9.1%, respectively. Medical patients had high, medium and low risk in 78.8, 19.8 and 1.4%. A hospital recommendation to continue thromboprophylaxis was given to 84.6% (95% CI 83.1-85.9%) of surgical and 64.9% (95% CI 59.1-70.6%) of medical patients and implemented in 96.6 and 94.3%, respectively. On the other hand, in patients without a respective hospital recommendation (15.4% of surgical and 35.1% of medical patients), thromboprophylaxis was continued in 65.3% of surgical and 73.1% of medical patients because of high risk. Our data illustrate acceptable rates of prophylaxis in surgical and medical patients in Germany. As the results show, it is essential that not only hospital physicians are aware of the actual risk at discharge, but office based physicians assess thromboembolic risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24996649     DOI: 10.1007/s11239-014-1095-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  16 in total

1.  Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; Holger J Schünemann; David D Gutterman; Sandra Zelman Lewis
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE.

Authors:  Frederick A Anderson; Samuel Z Goldhaber; Victor F Tapson; Jean-Francois Bergmann; Ajay K Kakkar; Bruno Deslandes; Wei Huang; Alexander T Cohen
Journal:  Am J Med       Date:  2010-12       Impact factor: 4.965

3.  Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Philippe Nicol; Eric Vicaut; Alexander G G Turpie; Roger D Yusen
Journal:  Ann Intern Med       Date:  2010-07-06       Impact factor: 25.391

4.  Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.

Authors:  David Bergqvist; Juan I Arcelus; Paulo Felicissimo
Journal:  Thromb Haemost       Date:  2011-12-21       Impact factor: 5.249

5.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

6.  Patient compliance with outpatient prophylaxis: an observational study.

Authors:  Clifford W Colwell; Pamela Pulido; Mary E Hardwick; Beverly A Morris
Journal:  Orthopedics       Date:  2005-02       Impact factor: 1.390

7.  [Compliance of patients undergoing thromboprophylaxis with enoxaparin: the COMFORT study].

Authors:  S Rübenacker; J Kaiser; M Guschmann
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

8.  [Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE study].

Authors:  R B Zotz; D Kauschat-Brüning; P Bramlage
Journal:  Dtsch Med Wochenschr       Date:  2009-10-13       Impact factor: 0.628

9.  Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Authors:  Susan R Kahn; Akbar Panju; William Geerts; Graham F Pineo; Louis Desjardins; Alexander G G Turpie; Stanislav Glezer; Lehana Thabane; Rolf J Sebaldt
Journal:  Thromb Res       Date:  2006-03-03       Impact factor: 3.944

10.  Venous thromboprophylaxis duration and adherence to international guidelines in patients undergoing major orthopaedic surgery: results of the international, longitudinal, observational DEIMOS registry.

Authors:  Juan I Arcelus; Paulo Felicissimo
Journal:  Thromb Res       Date:  2013-04-09       Impact factor: 3.944

View more
  1 in total

1.  Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization.

Authors:  Alex M Ebied; Jeremiah Jessee; Yiqing Chen; Jason Konopack; Nila Radhakrishnan; Christina E DeRemer
Journal:  TH Open       Date:  2020-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.